Literature DB >> 17416787

The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients.

Sandeep Dhindsa1, Vishal Bhatia, Gurkiran Dhindsa, Ajay Chaudhuri, Gopalakrishna Murthi Gollapudi, Paresh Dandona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17416787     DOI： 10.2337/dc07-0337

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  16 in total

Review 1.  Type 2 diabetes and bone fractures.

Authors:  Kendall F Moseley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

2.  Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth.

Authors:  Husam Ghanim; Sandeep Dhindsa; Manav Batra; Kelly Green; Sanaa Abuaysheh; Nitesh D Kuhadiya; Antoine Makdissi; Ajay Chaudhuri; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

3.  Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.

Authors:  Husam Ghanim; Sandeep Dhindsa; Manav Batra; Kelly Green; Sanaa Abuaysheh; Nitesh D Kuhadiya; Antoine Makdissi; Ajay Chaudhuri; Sartaj Sandhu; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  High aromatase activity in hypogonadal men is associated with higher spine bone mineral density, increased truncal fat and reduced lean mass.

Authors:  Lina E Aguirre; Georgia Colleluori; Kenneth E Fowler; Irum Zeb Jan; Kenneth Villareal; Clifford Qualls; David Robbins; Dennis T Villareal; Reina Armamento-Villareal
Journal:  Eur J Endocrinol       Date:  2015-08       Impact factor: 6.664

5.  Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover.

Authors:  Georgia Colleluori; Lina Aguirre; Richard Dorin; David Robbins; Dean Blevins; Yoann Barnouin; Rui Chen; Clifford Qualls; Dennis T Villareal; Reina Armamento-Villareal
Journal:  Bone       Date:  2017-03-16       Impact factor: 4.398

Review 6.  Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.

Authors:  Paresh Dandona; Sandeep Dhindsa
Journal:  J Clin Endocrinol Metab       Date:  2011-09       Impact factor: 5.958

7.  Testosterone concentrations in diabetic and nondiabetic obese men.

Authors:  Sandeep Dhindsa; Michael G Miller; Cecilia L McWhirter; Donald E Mager; Husam Ghanim; Ajay Chaudhuri; Paresh Dandona
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

Review 8.  A practical guide to male hypogonadism in the primary care setting.

Authors:  P Dandona; M T Rosenberg
Journal:  Int J Clin Pract       Date:  2010-05       Impact factor: 2.503

9.  Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.

Authors:  Sandeep Dhindsa; Husam Ghanim; Manav Batra; Nitesh D Kuhadiya; Sanaa Abuaysheh; Kelly Green; Antoine Makdissi; Ajay Chaudhuri; Paresh Dandona
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-18       Impact factor: 3.478

Review 10.  Hypogonadotropic Hypogonadism in Men With Diabesity.

Authors:  Sandeep Dhindsa; Husam Ghanim; Manav Batra; Paresh Dandona
Journal:  Diabetes Care       Date:  2018-07       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.